Who to Enroll in Parkinson Disease Prevention Trials?

Kellyann Niotis, Andrew B. West, Rachel Saunders-Pullman

Open source

DOI
10.1212/wnl.0000000000200812
Published
2022-08-16
Container
Neurology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1212/wnl.0000000000200812,
  title = {Who to Enroll in Parkinson Disease Prevention Trials?},
  author = {Kellyann Niotis and Andrew B. West and Rachel Saunders-Pullman},
  year = {2022},
  journal = {Neurology},
  doi = {10.1212/wnl.0000000000200812},
  url = {https://doi.org/10.1212/wnl.0000000000200812}
}

RIS

TY  - JOUR
TI  - Who to Enroll in Parkinson Disease Prevention Trials?
AU  - Kellyann Niotis
AU  - Andrew B. West
AU  - Rachel Saunders-Pullman
PY  - 2022
JO  - Neurology
DO  - 10.1212/wnl.0000000000200812
UR  - https://doi.org/10.1212/wnl.0000000000200812
ER  - 

APA

Niotis, K., West, A. B., & Saunders-Pullman, R. (2022). Who to Enroll in Parkinson Disease Prevention Trials?. Neurology. https://doi.org/10.1212/wnl.0000000000200812

Source records